+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Almac Group Ltd - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 39 Pages
  • March 2023
  • GlobalData
  • Almac Group
  • ID: 4058168
Almac Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - The publisher's summarization of the company's business strategy.
  • SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Almac Group Ltd (Almac) is a contract development and manufacturing organization. The company provides integrated services to pharmaceutical and biotechnology companies. The company offers a comprehensive range of services across the lifecycle of biopharmaceutical products which extend from research through pharmaceutical and clinical development to the commercialization of products. Its services portfolio encompasses diagnostics and biomarker development, clinical technologies, Active Pharmaceutical Ingredient (API) services and chemical development, pharmaceutical development, analytical services, clinical services and commercial services. The company operates through its subsidiaries in California, North Carolina and Pennsylvania in the US and Singapore. Almac is headquartered in Craigavon, Northern Ireland, the UK.

Almac Group Ltd Key Recent Developments

  • Dec 06, 2022: Almac Group completes first stage of GMP API facility expansion
  • Nov 15, 2022: Almac Group hosts internationally recognised chemistry R&D forum in Belfast
  • Oct 04, 2022: Almac Group Announces New COO and Appoints New Almac Pharma Services MD
  • Aug 18, 2022: Almac Group's Dundalk site achieves globally recognised health & safety and environmental management system certifications

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors' business structure and strategies with the publisher's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Almac Group Ltd - Key Facts
  • Almac Group Ltd - Key Employees
  • Almac Group Ltd - Key Employee Biographies
  • Almac Group Ltd - Major Products and Services
  • Almac Group Ltd - History
  • Almac Group Ltd - Company Statement
  • Almac Group Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Almac Group Ltd - Business Description
  • Almac Group Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Almac Group Ltd - Strengths
  • Almac Group Ltd - Weaknesses
  • Almac Group Ltd - Opportunities
  • Almac Group Ltd - Threats
  • Almac Group Ltd - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Almac Group Ltd, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Dec 06, 2022: Almac Group completes first stage of GMP API facility expansion
  • Nov 15, 2022: Almac Group hosts internationally recognised chemistry R&D forum in Belfast
  • Oct 04, 2022: Almac Group Announces New COO and Appoints New Almac Pharma Services MD
  • Aug 18, 2022: Almac Group’s Dundalk site achieves globally recognised health & safety and environmental management system certifications
  • Aug 11, 2022: Almac Group announces $65M expansion of North American Headquarters in Pennsylvania
  • Jun 30, 2022: Almac Group to Create 355 Jobs and Invest $93.5 Million in Pennsylvania Expansion
  • Jun 14, 2022: Almac Group records highest ever revenue, profit and employee numbers as £200 million global expansion plans announced
  • Apr 12, 2022: Almac Group announces £500,000 investment in NMR technology to enhance security, flexibility, and capacity in analytical services
Section 5 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Almac Group Ltd, Key Facts
  • Almac Group Ltd, Key Employees
  • Almac Group Ltd, Key Employee Biographies
  • Almac Group Ltd, Major Products and Services
  • Almac Group Ltd, History
  • Almac Group Ltd, Other Locations
  • Almac Group Ltd, Subsidiaries
  • Almac Group Ltd, Key Competitors
  • Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Almac Group Ltd, Recent Deals Summary
List of Figures
  • Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Almac Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aurelia Bioscience Ltd
  • Alcami Corp
  • Incyte Corp
  • Alexion Pharmaceuticals Inc
  • Pharmaceutical Product Development LLC
  • Codexis Inc
  • IQVIA Holdings Inc
  • Cobra Biologics Ltd
  • Aurelia Bioscience Ltd
  • ICON Plc
  • IQVIA Holdings Inc
  • inVentiv Health Clinical LLC
  • Cobra Biologics Ltd
  • Pharmaceutical Product Development LLC
  • Codexis Inc
  • Charles River Laboratories International Inc
  • Alcami Corp